We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$485M
AUM Growth
+$20.2M
Cap. Flow
-$1.74M
Cap. Flow %
-0.36%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$2.41M
2
INDA icon
iShares MSCI India ETF
INDA
+$945K

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$5.1M

Sector Composition

Rank Sector Weight
1 Healthcare 95.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$314M 64.69%
15,966,038
– –
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$123M 25.39%
2,679,835
+50,000
+2% +$2.41M
ALKS icon
3
Alkermes
ALKS
$8.82B
$26.3M 5.42%
892,400
-138,239
-13% -$5.1M
INDA icon
4
iShares MSCI India ETF
INDA
$6.71B
$10.6M 2.19%
320,000
+30,000
+10% +$945K
EPI icon
5
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$9.92M 2.04%
400,000
– –
CLDX icon
6
Celldex Therapeutics
CLDX
$2.77B
$1.25M 0.26%
420,847
– –

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q4 2018 Portfolio in Review

As of Q4 2018, Meditor Group held 6 positions worth $485M, up 4.3% from $465M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier.

  • Meditor Group added most to Esperion Therapeutics in Q4 2018, an estimated $2.41M increase.
  • Meditor Group's biggest Q4 2018 reduction was Alkermes, cutting an estimated $5.1M.
  • Meditor Group's ten largest holdings make up 100% of its $485M portfolio in Q4 2018.
  • Meditor Group opened 0 new positions and closed 0 in Q4 2018.
  • Meditor Group's portfolio value rose 4.3% quarter-over-quarter to $485M.

Based on Meditor Group's 13F filing for Q4 2018, filed 2 Jan 2019.